Fri.Jan 14, 2022

article thumbnail

Otsuka backs GrayMatters’ digital wearable tech for mental disorders

pharmaphorum

Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital health approach to the management of mental illness. Otsuka Medical Devices is also taking some rights to GrayMatters’ platform – called Prism – in Japan and some other Asian countries in connection with the financing, which was supported by Joy Ventures, J-Ventures, J-Impact, and existing backers Marius Nacht and Joyance Ventures.

article thumbnail

MedPAC: Majority of Medicare beneficiaries to be on MA by 2023, but coding issues remain rampant

Fierce Healthcare

MedPAC: Majority of Medicare beneficiaries to be on MA by 2023, but coding issues remain rampant. rking. Fri, 01/14/2022 - 16:37.

124
124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EMA sets out proposals to reform EU’s clinical trials framework

pharmaphorum

The European Commission, EMA and national regulators within the EU have launched an initiative to change the way clinical trials are designed and run in order to position the bloc as an international “focal point” for clinical research. The broad strokes of the proposals are laid out in a document entitled Accelerating Clinical Trials in the EU (ACT EU) that lists priority actions that will be taken, including measures to allow greater use of innovative clinical trial designs.

article thumbnail

HHS renews COVID-19 public health emergency order for another 90 days

Fierce Healthcare

HHS renews COVID-19 public health emergency order for another 90 days. rking. Fri, 01/14/2022 - 11:27.

136
136
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The evolution of clinical trials: the pharmaphorum podcast

pharmaphorum

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.

article thumbnail

Hospitals forced to delay patient discharges as nursing homes and rehab centers face major staff shortages

Fierce Healthcare

Hospitals forced to delay patient discharges as nursing homes and rehab centers face major staff shortages. dmuoio. Fri, 01/14/2022 - 16:07.

More Trending

article thumbnail

DaVita acquires MedSleuth to streamline transplant process for kidney and liver candidates

Fierce Healthcare

DaVita acquires MedSleuth to streamline transplant process for kidney and liver candidates. rtorrence. Fri, 01/14/2022 - 15:36.

115
115
article thumbnail

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health: CPhI Worldwide Report

Pharma Mirror

Amsterdam, CPhI Worldwide – the world’s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) – releases the final part of its annual report with far reaching predictions for 2022 and beyond into 2025 for the nutraceuticals market. The findings explore the long-term trends underway in the global nutraceutical industry, with consumers predicted to increase spending on natural products and sustainable formulations that can offer ‘preventative or proactive’ health b

52
article thumbnail

Kaiser Permanente, Mass General back Providence spinoff DexCare's $50M series B round

Fierce Healthcare

Kaiser Permanente, Mass General back Providence spinoff DexCare's $50M series B round. rtorrence. Fri, 01/14/2022 - 11:34.

110
110
article thumbnail

Pharma R&D investment report shows positive signs: Deloitte

Outsourcing Pharma

According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Healthcare conferences to put on your calendar for 2022

Fierce Healthcare

Healthcare conferences to put on your calendar for 2022. hlandi. Fri, 01/14/2022 - 13:08.

123
123
article thumbnail

Why You Should Improve Your Diet a Little Every Day

Tria Health Blog

Sticking to a diet can be challenging, but not impossible. It’s important to take the right steps if you are considering making an impactful change in your diet.

40
article thumbnail

Industry Voices—Why the new hospital price transparency rules miss the mark

Fierce Healthcare

Industry Voices—Why the new hospital price transparency rules miss the mark. pminemyer. Fri, 01/14/2022 - 11:27.

Hospitals 109
article thumbnail

Gates Foundation supports HIV and malaria research

Pharma Times

Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Chutes & Ladders—Amedisys announces CEO hand-off; Mercy adds 5 to senior leadership team

Fierce Healthcare

Chutes & Ladders—Amedisys announces CEO hand-off; Mercy adds 5 to senior leadership team. dmuoio. Fri, 01/14/2022 - 10:02.

93
article thumbnail

While Omicron continues to dominate across the world, COVID-19 travel requirements remain

Pharma Times

Djokovic drama causes a racket: so how would the UK respond?

38
article thumbnail

Healthcare conferences to put on your calendar for 2024

Fierce Healthcare

Looking for healthcare events in 2024? We rounded up some of the top conferences, both virtual and live, that are on the calendar. | Here's our roundup of some of the top events in healthcare scheduled in 2024.

52
article thumbnail

Sustainability in the microbiology lab

Pharmig

Unless you’ve been living under a rock for the last few years, you can’t help but have noticed the word sustainability seeping into every single industry. The post Sustainability in the microbiology lab appeared first on Pharmig.

52
article thumbnail

Oscar Health reveals data breach caused by printing error

Fierce Healthcare

Oscar Health reveals data breach caused by printing error. pminemyer. Fri, 01/14/2022 - 15:03.

63
article thumbnail

Senate panel backs Biden’s FDA selection Robert Califf

pharmaphorum

Robert Califf has cleared another stage on his return journey to the top job at the FDA, after the influential Senate committee on Health, Education, Labour and Pensions (HELP) voted by 13 to eight to support his nomination by President Joe Biden. Califf was nominated by Biden as FDA commissioner last November, ending a search for a permanent replacement for current acting commissioner Janet Woodcock after almost a full year of the new administration.

FDA 52